Comparison of Serologic Assays for Middle East Respiratory Syndrome Coronavirus

Comparison of Serologic Assays for Middle East Respiratory Syndrome Coronavirus

Middle East respiratory syndrome coronavirus (MERS-CoV) was detected in humans in 2012. Since then, sporadic outbreaks with primary transmission through dromedary camels to humans and outbreaks in healthcare settings have shown that MERS-CoV continues to pose a threat to human health. Several serolo...

Full description

Bibliographic Details
Main Authors: Ruth Harvey, Giada Mattiuzzo, Mark Hassall, Andrea Sieberg, Marcel A. Müller, Christian Drosten, Peter Rigsby, Christopher J. Oxenford
Format: Article
Language:English
Published: Centers for Disease Control and Prevention 2019-10-01
Series:Emerging Infectious Diseases
Subjects:
Middle East respiratory syndrome coronavirus
MERS-CoV
spike
antibodies
diagnostics
serology
Online Access:https://wwwnc.cdc.gov/eid/article/25/10/19-0497_article

Internet

https://wwwnc.cdc.gov/eid/article/25/10/19-0497_article

Similar Items